Feedback / Questions
REX-8756 - Recludix Pharma
https://www.globenewswire.com/news-release/2025/12/16/3206147/0/en/Recludix-Pharma-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-REX-8756-an-Oral-STAT6-Inhibitor-to-Enter-into-the-Clinic.html
Dec 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next